Endogenous inhibitor of prostaglandin biosynthesis in inflammation
Abstract:
Rat serum exhibits a concentration-related inhibition of PG biosynthesis by rat peritoneal leucocytes phagocytosing killed bacteria. The serum inhibitory potency is increased by inducing carrageenan foot oedema in animals whereas it is not altered by dextran oedema. The increase of the inhibitory activity of serum from carrageenan-treated rats develops in a time-dependent way reaching its maximum at 24 h. Since the increased inhibitory activity does not occur following indomethacin administration we suggest that PG formation at the inflammatory site may stimulate the ability of serum to inhibit PG biosynthesis.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Feedback Inhibition
IP3/DAG Signaling Pathway


